Publication Date
2-15-2023
Journal
The American Journal of Cardiology
Abstract
COVID-19 results in increased incidence of cardiac arrhythmias, including atrial fibrillation (AF). However, little is known about the combined effect of AF and COVID-19 on patient outcomes. This study aimed to determine if AF, specifically new-onset AF (NOAF), is associated with increased risk of mortality and major adverse cardiovascular events (MACEs) in hospitalized patients with COVID-19. This multicenter retrospective analysis identified 2,732 patients with COVID-19 admitted between March and December 2020. Data points were manually reviewed in the patients' electronic health records. Multivariate logistic regression was used to assess if AF was associated with death or MACE. Patients with AF (6.4%) had an increased risk of mortality (risk ratio 2.249, 95% confidence interval [CI] 1.766 to 2.864, p
Keywords
Humans, Atrial Fibrillation, Retrospective Studies, Follow-Up Studies, Risk Factors, COVID-19
Included in
Cardiology Commons, Cardiovascular Diseases Commons, COVID-19 Commons, Emergency Medicine Commons, Epidemiology Commons, Health Services Administration Commons, Infectious Disease Commons